The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Apr. 14, 2015

Filed:

Jun. 25, 2014
Applicant:

Isis Pharmaceuticals, Inc., Carlsbad, CA (US);

Inventors:

Eric E. Swayze, Encinitas, CA (US);

Andrew M. Siwkowski, Carlsbad, CA (US);

Balkrishen Bhat, Carlsbad, CA (US);

Thazha P. Prakash, Carlsbad, CA (US);

Charles Allerson, San Diego, CA (US);

Punit P. Seth, Carlsbad, CA (US);

Assignee:

Isis Pharmaceuticals, Inc., Carlsbad, CA (US);

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
G01N 33/53 (2006.01); C12N 5/00 (2006.01); C07H 19/10 (2006.01); C07H 19/20 (2006.01); C07H 21/00 (2006.01); C12N 15/113 (2010.01); C12N 15/11 (2006.01);
U.S. Cl.
CPC ...
C12N 15/113 (2013.01); C07H 19/10 (2013.01); C07H 19/20 (2013.01); C07H 21/00 (2013.01); C12N 15/111 (2013.01); C12N 2310/323 (2013.01); C12N 2320/51 (2013.01);
Abstract

The present disclosure describes tetrahydropyran nucleoside analogs, oligomeric compounds prepared therefrom and methods of using the oligomeric compounds. More particularly, tetrahydropyran nucleoside analogs are provided, having one or more chiral substituents, that are useful for enhancing properties of oligomeric compounds including nuclease resistance and binding affinity. In some embodiments, the oligomeric compounds provided herein hybridize to a portion of a target RNA resulting in loss of normal function of the target RNA.


Find Patent Forward Citations

Loading…